comparemela.com
Home
Live Updates
Nt Specialty - Breaking News
Pages:
5
6
7
8
9
10
11
Page 4 - Nt Specialty News Today : Breaking News, Live Updates & Top Stories | Vimarsana
FDA Approves Omalizumab for Multiple Food Allergy
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.
United states
Division of pulmonology
Drug administration
Kelly stone
Critical care
Drug evaluation
Food allergy
Food hypersensitivity
Nt specialty
Ead and neck surgery ent speciality
Allergy induced asthma
Allergic asthma
Immunoglobulin e
Ebrile response
Immunoglobulin a
Pain management
Europe Greenlights Two Avian Flu Vaccines
The vaccines, Celldemic and Incellipan, protect against the H5N1 subtype of the influenza A virus.
Medicinal products
Human use
European medicines agency
Adverse effects of vaccines
Pediatric vaccines
Adult vaccines
Influenza pandemic
Patient safety
Avian influenza
Avian flu
Bird flu
Ird influenza
Biologic therapy
Nt specialty
Ead and neck surgery ent speciality
Adverse effects
Dupilumab for EoE: How Is it Improving Treatment?
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.
University of north carolina
North carolina
United states
New york
Regeneron sanofi
Philip katz
Evan dellon
Drug administration
University of north carolina at chapel hill
Major advance
Weill cornell medicine
New york city
Medscape medical
New england journal
Esophageal diseases
Chapel hill
Tapinarof Under FDA Review for Treating Atopic Dermatitis
Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.
Drug administration
Dermavant sciences
New drug application
Validated investigator global assessment
Atopic dermatitis
Atopic eczema
Nt specialty
Ead and neck surgery ent speciality
Contact dermatitis
Common cold
Cute nasopharyngitis
Plaque psoriasis
Skin and soft tissue infection
FDA Approves Drug to Reduce Accidental Food Allergies
The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.
Drug administration
Kelly stone
Drug evaluation
Food allergy
Food hypersensitivity
Nt specialty
Ead and neck surgery ent speciality
Allergy induced asthma
Allergic asthma
Pain management
Ebrile response
Biologic therapy
Ainful joint
Joint pain
Adverse effects
Side effects
vimarsana © 2020. All Rights Reserved.